Relapsed and/or Refractory B-cell Lymphoma
1 clinical trials · Condition
◉ Watch Relapsed and/or Refractory B-cell Lymphoma
| Record | Firm | Date |
|---|---|---|
| Study of KITE-363 or KITE-753 in Participants With Relapsed and/or Refractory B-cell Lymphoma (NCT04989803) | Kite, A Gilead Company | 2021-10-27 |
Track Relapsed and/or Refractory B-cell Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.